MedPath
FDA Approval

CARBOPROST TROMETHAMINE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 22, 2023
Labeling Type
Human Prescription Drug Label
Carboprost tromethamine(250 ug in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Caplin Steriles Limited

Caplin Steriles Limited

650744670

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CARBOPROST TROMETHAMINE

Product Details

NDC Product Code
65145-132
Application Number
ANDA216882
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR
Effective Date
February 22, 2023
Code: U4526F86FJClass: ACTIMQuantity: 250 ug in 1 mL
TROMETHAMINEInactive
Code: 023C2WHX2VClass: IACTQuantity: 83 ug in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 9 mg in 1 mL
BENZYL ALCOHOLInactive
Code: LKG8494WBHClass: IACTQuantity: 9.45 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
© Copyright 2025. All Rights Reserved by MedPath